Cliff Asness's VYGR Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 232,681 shares of Voyager Therapeutics, Inc. (VYGR) worth $898,149, representing 0.00% of the portfolio. First purchased in 2018-Q2, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in VYGR, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 440,465 shares. Largest reduction occurred in Q2 2024, reducing 291,259 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Voyager Therapeutics (VYGR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Voyager Therapeutics (VYGR) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +72,644 | Add 45.39% | 232,681 | $3.86 |
| Q4 2025 | -16,179 | Reduce 9.18% | 160,037 | $3.93 |
| Q3 2025 | -106,990 | Reduce 37.78% | 176,216 | $4.67 |
| Q2 2025 | -212,054 | Reduce 42.82% | 283,206 | $3.11 |
| Q1 2025 | +317,927 | Add 179.28% | 495,260 | $3.38 |
| Q4 2024 | -71,290 | Reduce 28.67% | 177,333 | $5.67 |
| Q3 2024 | -253,752 | Reduce 50.51% | 248,623 | $5.85 |
| Q2 2024 | -291,259 | Reduce 36.70% | 502,375 | $7.91 |
| Q1 2024 | +154,347 | Add 24.14% | 793,634 | $9.31 |
| Q4 2023 | +440,465 | Add 221.54% | 639,287 | $8.44 |
| Q3 2023 | +198,822 | New Buy | 198,822 | $7.75 |
| Q3 2021 | -166,330 | Sold Out | 0 | $0.00 |
| Q2 2021 | -196,108 | Reduce 54.11% | 166,330 | $4.13 |
| Q1 2021 | +195,083 | Add 116.57% | 362,438 | $4.71 |
| Q4 2020 | +141,435 | Add 545.66% | 167,355 | $7.15 |
| Q3 2020 | -25,644 | Reduce 49.73% | 25,920 | $10.69 |
| Q2 2020 | -6,966 | Reduce 11.90% | 51,564 | $12.63 |
| Q1 2020 | -11,926 | Reduce 16.93% | 58,530 | $9.16 |
| Q4 2019 | -7,449 | Reduce 9.56% | 70,456 | $13.95 |
| Q3 2019 | +57,299 | Add 278.07% | 77,905 | $17.21 |
| Q2 2019 | -4,059 | Reduce 16.46% | 20,606 | $27.23 |
| Q1 2019 | -24,924 | Reduce 50.26% | 24,665 | $19.14 |
| Q4 2018 | +30,608 | Add 161.26% | 49,589 | $9.40 |
| Q3 2018 | -4,346 | Reduce 18.63% | 18,981 | $18.91 |
| Q2 2018 | +23,327 | New Buy | 23,327 | $19.55 |
Cliff Asness's Voyager Therapeutics Investment FAQs
Cliff Asness first purchased Voyager Therapeutics, Inc. (VYGR) in Q2 2018, acquiring 23,327 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Voyager Therapeutics, Inc. (VYGR) for 25 quarters since Q2 2018.
Cliff Asness's largest addition to Voyager Therapeutics, Inc. (VYGR) was in Q4 2023, adding 639,287 shares worth $5.4 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 232,681 shares of Voyager Therapeutics, Inc. (VYGR), valued at approximately $898,149.
As of the Q1 2026 filing, Voyager Therapeutics, Inc. (VYGR) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Voyager Therapeutics, Inc. (VYGR) was 793,634 shares, as reported at the end of Q1 2024.